|
INDIA BUSINESS WORLD - 1st March - TO - 15th March - 2009
AUROBINDO GETS US NOD FOR ANTI-HIV INFECTION TABLETS
Aurobindo Pharma has said that it has received the US health administrator’s approval for Lopinavir/Ritonavir tablets used in the treatment of HIV infections. In a filing to the Bombay Stock Exchange, the pharma company said it has received approval from US Food and Drug Administration (USFDA) for tablets that are in the strength of 100/25 mg and 200/50 mg. Lopinavir/Ritonavir tablets are used in the treatment of HIV infection in adults and children above the age of two years, the filing added. Aurobindo now has a total of 93 abbreviated new drug application (ANDA) approvals from USFDA.
|
